Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/25/2012
Desert Hematology Oncology Medical Group
mi
from
Rancho Mirage, CA
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/25/2012
Desert Hematology Oncology Medical Group
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/25/2012
Kansas City Cancer Center, LLC
mi
from
Overland Park, KA
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/25/2012
Kansas City Cancer Center, LLC
mi
from
Overland Park, KA
Click here to add this to my saved trials
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/25/2012
Hackensack University Medical Center
mi
from
Hackensack, NJ
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/25/2012
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
Efficacy of Inhaling Bronchodilator Medications in Patients With Chronic Obstructive Pulmonary Disease Who Have a Low Peak Inspiratory Flow Rate
Status: Enrolling
Updated:  9/28/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
Efficacy of Inhaling Bronchodilator Medications in Patients With Chronic Obstructive Pulmonary Disease Who Have a Low Peak Inspiratory Flow Rate
Status: Enrolling
Updated: 9/28/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  10/2/2012
National Jewish Health
mi
from
Denver, CO
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 10/2/2012
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole Versus Perphenazine in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated:  10/12/2012
Department of Veterans Affairs Eastern Colorado Healthcare System
mi
from
Denver, CO
Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole Versus Perphenazine in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated: 10/12/2012
Department of Veterans Affairs Eastern Colorado Healthcare System
mi
from
Denver, CO
Click here to add this to my saved trials
Assessment of Sleep Apnea and Its Causes Before and After Weight Loss Surgery
Understanding the Role Obesity Plays in the Pathogenesis of Obstructive Sleep Apnea
Status: Enrolling
Updated:  10/19/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Assessment of Sleep Apnea and Its Causes Before and After Weight Loss Surgery
Understanding the Role Obesity Plays in the Pathogenesis of Obstructive Sleep Apnea
Status: Enrolling
Updated: 10/19/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The Efficacy of Doxazosin for Cocaine Users
Doxazosin, An Alpha-1 Adrenergic Antagonist, for Cocaine Dependence: Pilot Study
Status: Enrolling
Updated:  10/22/2012
Baylor College of Medicine - Michael E. DeBakey VA Medical Center
mi
from
Houston, TX
The Efficacy of Doxazosin for Cocaine Users
Doxazosin, An Alpha-1 Adrenergic Antagonist, for Cocaine Dependence: Pilot Study
Status: Enrolling
Updated: 10/22/2012
Baylor College of Medicine - Michael E. DeBakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Promoting Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) Through New Technology and Health Coaching
Next Generation Technology for Chronic Care Self Management
Status: Enrolling
Updated:  10/24/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Promoting Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) Through New Technology and Health Coaching
Next Generation Technology for Chronic Care Self Management
Status: Enrolling
Updated: 10/24/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Nemours Children's Clinic
mi
from
Jacksonville, FL
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Nemours Childrens Clinic Orlando
mi
from
Orlando, FL
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Nemours Childrens Clinic Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
University of Kentucky
mi
from
Lexington, KY
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Children's Hospital - Boston
mi
from
Boston, MA
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
University of Michigan
mi
from
Ann Arbor, MI
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Saint Louis University
mi
from
St. Louis, MO
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
University of New Mexico
mi
from
Albuquerque, NM
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Cohen Children's Medical Center of NY
mi
from
New Hyde Park, NY
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Cohen Children's Medical Center of NY
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
UNC Chapel Hill
mi
from
CHapel Hill, NC
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Akron Children's Hospital
mi
from
Akron, OH
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Dayton Children's
mi
from
Dayton, OH
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Dayton Children's
mi
from
Dayton, OH
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Toledo Children's Hospital CF Research Center
mi
from
Toledo, OH
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Toledo Children's Hospital CF Research Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
PennState Milton S. Hershey Medical Center
mi
from
Hershey, PA
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
PennState Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Baylor College of Medicine
mi
from
Houston, TX
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
University of Utah
mi
from
Salt Lake City, UT
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated:  10/24/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)
Status: Enrolling
Updated: 10/24/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure
Pulmonary Function Testing in Infants With Respiratory Insufficiency While Receiving High Flow Nasal Cannula (HFNC) Versus Nasal Continuous Positive Airway Pressure (nCPAP)
Status: Enrolling
Updated:  10/26/2012
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure
Pulmonary Function Testing in Infants With Respiratory Insufficiency While Receiving High Flow Nasal Cannula (HFNC) Versus Nasal Continuous Positive Airway Pressure (nCPAP)
Status: Enrolling
Updated: 10/26/2012
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Gateway Community Services
mi
from
Jacksonville, FL
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Gateway Community Services
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Maryhaven
mi
from
Columbus, OH
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Maryhaven
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Penn Presbyterian
mi
from
Philadelphia, PA
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Penn Presbyterian
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Addiction Medicine Services
mi
from
Pittsburgh, PA
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Addiction Medicine Services
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Morris Village/LRADAC
mi
from
Columbia, SC
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Morris Village/LRADAC
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated:  10/26/2012
Nexus Recovery Services
mi
from
Dallas, TX
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)
Status: Enrolling
Updated: 10/26/2012
Nexus Recovery Services
mi
from
Dallas, TX
Click here to add this to my saved trials
Continuous Positive Airway Pressure (CPAP) Titration and Treatment Versus Auto-adjusting Positive Airway Treatment (APAP) for Sleep Apnea
Portable Monitoring and APAP Treatment for Diagnosis and Treatment of OSA
Status: Enrolling
Updated:  10/29/2012
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Continuous Positive Airway Pressure (CPAP) Titration and Treatment Versus Auto-adjusting Positive Airway Treatment (APAP) for Sleep Apnea
Portable Monitoring and APAP Treatment for Diagnosis and Treatment of OSA
Status: Enrolling
Updated: 10/29/2012
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University of Arizona College of Medicine
mi
from
Tucson, AZ
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
National Jewish Health
mi
from
Denver, CO
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Emory University
mi
from
Atlanta, GA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University of Chicago
mi
from
Chicago, IL
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials